Modeling combination chemo‐immunotherapy for heterogeneous tumors
Abstract Hypermutable cancers create opportunities for the development of various immunotherapies, such as immune checkpoint blockade (ICB) therapy. However, emergent studies have revealed that many hypermutated tumors have poor prognosis due to heterogeneous tumor antigen landscapes, yet the underl...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2025-09-01
|
| Seri Bilgileri: | Quantitative Biology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/qub2.98 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|